These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 4834709)
41. [Treatment of outpatients with high doses of haloperidol]. Shopsin B; Kline N Acta Psiquiatr Psicol Am Lat; 1981 Jul; 27(3):236-42. PubMed ID: 7348083 [No Abstract] [Full Text] [Related]
42. Withdrawal syndromes associated with antipsychotic drugs. Gardos G; Cole JO; Tarsy D Am J Psychiatry; 1978 Nov; 135(11):1321-4. PubMed ID: 30287 [TBL] [Abstract][Full Text] [Related]
43. Prevention and management of tardive dyskinesia. Crane GE Am J Psychiatry; 1972 Oct; 129(4):466-7. PubMed ID: 5071149 [No Abstract] [Full Text] [Related]
44. Haloperidol in psychiatry. Med Lett Drugs Ther; 1975 Jan; 17(3):11-2. PubMed ID: 1092991 [No Abstract] [Full Text] [Related]
45. Withdrawal akathisia: case reports and a proposed classification of chronic akathisia. Lang AE Mov Disord; 1994 Mar; 9(2):188-92. PubMed ID: 8196681 [TBL] [Abstract][Full Text] [Related]
46. Neuroleptic discontinuation and tardive dyskinesia risk. Sherr JD; Medoff D; Thaker G Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483 [No Abstract] [Full Text] [Related]
47. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action. Huygens H; Vereecken JL; Tanghe A Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374 [No Abstract] [Full Text] [Related]
49. [On the problem of the therapeutical axis symptom of neuroleptic medicaments]. Glatzel J Psychiatr Neurol Med Psychol (Leipz); 1968 Aug; 20(8):286-95. PubMed ID: 5731884 [No Abstract] [Full Text] [Related]
50. Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics? Henkel V; Mergl R; Schäfer M; Rujescu D; Möller HJ; Hegerl U Pharmacopsychiatry; 2004 May; 37(3):110-8. PubMed ID: 15138894 [TBL] [Abstract][Full Text] [Related]
51. Haloperidol-induced tardive dyskinesia in a 10-year-old girl. Petty LK; Spar CJ Am J Psychiatry; 1980 Jun; 137(6):745-6. PubMed ID: 7377407 [No Abstract] [Full Text] [Related]
52. Movement disorders in patients treated with long-acting injectable antipsychotic drugs. Bransgrove LL; Kelly MW Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473 [TBL] [Abstract][Full Text] [Related]
53. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation. Mendhekar DN; Jiloha RC Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023 [No Abstract] [Full Text] [Related]
55. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)]. Bourgeois M; Bouey P Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864 [No Abstract] [Full Text] [Related]
56. Drug induced extrapyramidal effects--a review. Coleman JH; Hayes PE Dis Nerv Syst; 1975 Oct; 36(10):591-3. PubMed ID: 1100334 [No Abstract] [Full Text] [Related]